Why is $NRXP stock down today?
NRX Pharmaceuticals, Inc. Common Stock · Pharmaceutical Preparations
Why is $NRXP down today?
The likely driver
- ›Revenue $1.2M, +379% vs a year ago, +5.3% vs last quarter
- ›Net loss $2.2M, narrowed from $5.9M a year ago
- ›Diluted EPS -$0.05
Catch the next move like NRXP before the open
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Today’s scanner timeline
- 3:46 PMBig % mover alert
- 3:44 PMUnusual volume (RVOL) alert
- 3:16 PMUnusual volume (RVOL) alert
- 2:30 PMBig % mover alert
- 2:30 PMUnusual volume (RVOL) alert
- 1:05 PMUnusual volume (RVOL) alert
- 11:44 AMUnusual volume (RVOL) alert
- 9:32 AMBig % mover alert
- 9:31 AMUnusual volume (RVOL) alert
- 6:32 AMBig % mover alert
Unusual-volume alerts often fire before the news is widely reported. This is when our scanner first flagged NRXP today.
Earlier scanner activity on NRXP
- Nov 13Big % mover alert
- Nov 13Unusual volume (RVOL) alert
- Nov 13Unusual volume (RVOL) alert
- Nov 13Unusual volume (RVOL) alert
- Nov 12Unusual volume (RVOL) alert
- Nov 12Big % mover alert
- Nov 12Unusual volume (RVOL) alert
- Nov 11Big % mover alert
- Nov 11Unusual volume (RVOL) alert
- Nov 11Unusual volume (RVOL) alert
- Nov 11Unusual volume (RVOL) alert
- Nov 11Big % mover alert
Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.
Get free $NRXP alerts the moment volume spikes
Our scanner flagged $NRXP 126 times in the last 30 days. Create a free account to track $NRXP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Other stocks moving today
Each opens that stock’s own why-is-it-moving page.
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.